Midazolam hydrochloride

Product NDC
64679-764
11-digit product format
646790764
Labeler code
64679
Product ID
64679-764_209d926b-f1af-49e2-be94-53c7035b0b93
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Midazolam hydrochloride
Dosage form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Labeler
Wockhardt USA LLC.
Application
ANDA078511
Marketing category
ANDA
Marketing start
2008-11-10
Marketing end
0000-00-00
Substance
MIDAZOLAM HYDROCHLORIDE
Active strength
1 mg/mL
Pharmacologic classes
Benzodiazepine [EPC],Benzodiazepines [CS]
NDC exclude flag
E
Listing certified through
2018-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct64679-764DDiscontinued by firm2026-10-05
excluded packagepackage64679-76464679-764-01DDiscontinued by firm2026-10-05
excluded packagepackage64679-76464679-764-02DDiscontinued by firm2026-10-05
excluded packagepackage64679-76464679-764-03DDiscontinued by firm2026-10-05
excluded packagepackage64679-76464679-764-04DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 110 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductDDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage64679-764-01DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage64679-764-04DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage64679-764-02DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage64679-764-03DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductDDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage64679-764-01DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage64679-764-04DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage64679-764-02DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage64679-764-03DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproductDDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage64679-764-01DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage64679-764-04DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage64679-764-02DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage64679-764-03DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproductDDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage64679-764-01DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage64679-764-04DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage64679-764-02DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage64679-764-03DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductDDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage64679-764-01DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage64679-764-04DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage64679-764-02DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage64679-764-03DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductDDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage64679-764-01DDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage64679-764-04DDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage64679-764-02DDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage64679-764-03DDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproductDDiscontinued by firm302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage64679-764-01DDiscontinued by firm302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage64679-764-04DDiscontinued by firm302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage64679-764-02DDiscontinued by firm302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage64679-764-03DDiscontinued by firm302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproductDDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage64679-764-01DDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage64679-764-04DDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage64679-764-02DDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage64679-764-03DDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproductDDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage64679-764-01DDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage64679-764-04DDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage64679-764-02DDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage64679-764-03DDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductIInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage64679-764-03IInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage64679-764-02IInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage64679-764-04IInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage64679-764-01IInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproductIInactivated by FDA367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage64679-764-03IInactivated by FDA367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage64679-764-02IInactivated by FDA367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage64679-764-04IInactivated by FDA367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage64679-764-01IInactivated by FDA367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproductIInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage64679-764-03IInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage64679-764-02IInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage64679-764-04IInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage64679-764-01IInactivated by FDA557ba5c1ecfa…9c80585c8c6e…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A078511-001MIDAZOLAM HYDROCHLORIDEMIDAZOLAM HYDROCHLORIDEEQ 1MG BASE/MLINJECTABLE / INJECTION2008-11-10
A078511-002MIDAZOLAM HYDROCHLORIDEMIDAZOLAM HYDROCHLORIDEEQ 5MG BASE/MLINJECTABLE / INJECTION2008-11-10

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A078511-001MIDAZOLAM HYDROCHLORIDEEQ 1MG BASE/MLINJECTABLE / INJECTION2008-11-1084e616aacf4f…
2026-09-14 22:38:342026-08A078511-002MIDAZOLAM HYDROCHLORIDEEQ 5MG BASE/MLINJECTABLE / INJECTION2008-11-1084e616aacf4f…
2026-08-18 06:07:402026-07A078511-001MIDAZOLAM HYDROCHLORIDEEQ 1MG BASE/MLINJECTABLE / INJECTION2008-11-10caaa826d4ba7…
2026-08-18 06:07:402026-07A078511-002MIDAZOLAM HYDROCHLORIDEEQ 5MG BASE/MLINJECTABLE / INJECTION2008-11-10caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A078511-001MIDAZOLAM HYDROCHLORIDEEQ 1MG BASE/MLINJECTABLE / INJECTION2008-11-10011fe1cb6892…
2026-02-19 14:30 UTC2026-02A078511-002MIDAZOLAM HYDROCHLORIDEEQ 5MG BASE/MLINJECTABLE / INJECTION2008-11-10011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A078511-001MIDAZOLAM HYDROCHLORIDEEQ 1MG BASE/MLINJECTABLE / INJECTION2008-11-1031067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A078511-002MIDAZOLAM HYDROCHLORIDEEQ 5MG BASE/MLINJECTABLE / INJECTION2008-11-1031067a03dcf5…
2025-08-23 18:47 UTC2025-08A078511-001MIDAZOLAM HYDROCHLORIDEEQ 1MG BASE/MLINJECTABLE / INJECTION2008-11-106a471c1ec25d…
2025-08-23 18:47 UTC2025-08A078511-002MIDAZOLAM HYDROCHLORIDEEQ 5MG BASE/MLINJECTABLE / INJECTION2008-11-106a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A078511-001MIDAZOLAM HYDROCHLORIDEEQ 1MG BASE/MLINJECTABLE / INJECTION2008-11-10fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A078511-002MIDAZOLAM HYDROCHLORIDEEQ 5MG BASE/MLINJECTABLE / INJECTION2008-11-10fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A078511-001MIDAZOLAM HYDROCHLORIDEEQ 1MG BASE/MLINJECTABLE / INJECTION2008-11-10b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A078511-002MIDAZOLAM HYDROCHLORIDEEQ 5MG BASE/MLINJECTABLE / INJECTION2008-11-10b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A078511-001MIDAZOLAM HYDROCHLORIDEEQ 1MG BASE/MLINJECTABLE / INJECTION2008-11-1003ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A078511-002MIDAZOLAM HYDROCHLORIDEEQ 5MG BASE/MLINJECTABLE / INJECTION2008-11-1003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A078511-001MIDAZOLAM HYDROCHLORIDEEQ 1MG BASE/MLINJECTABLE / INJECTION2008-11-102680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A078511-002MIDAZOLAM HYDROCHLORIDEEQ 5MG BASE/MLINJECTABLE / INJECTION2008-11-102680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A078511-001MIDAZOLAM HYDROCHLORIDEEQ 1MG BASE/MLINJECTABLE / INJECTION2008-11-105bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A078511-002MIDAZOLAM HYDROCHLORIDEEQ 5MG BASE/MLINJECTABLE / INJECTION2008-11-105bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A078511-001MIDAZOLAM HYDROCHLORIDEEQ 1MG BASE/MLINJECTABLE / INJECTION2008-11-10d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A078511-002MIDAZOLAM HYDROCHLORIDEEQ 5MG BASE/MLINJECTABLE / INJECTION2008-11-10d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A078511-001MIDAZOLAM HYDROCHLORIDEEQ 1MG BASE/MLINJECTABLE / INJECTION2008-11-10d06236e962d9…
2024-10-29 15:01 UTC2024-10A078511-002MIDAZOLAM HYDROCHLORIDEEQ 5MG BASE/MLINJECTABLE / INJECTION2008-11-10d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A078511-001MIDAZOLAM HYDROCHLORIDEEQ 1MG BASE/MLINJECTABLE / INJECTION2008-11-1079d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A078511-002MIDAZOLAM HYDROCHLORIDEEQ 5MG BASE/MLINJECTABLE / INJECTION2008-11-1079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A078511-001MIDAZOLAM HYDROCHLORIDEEQ 1MG BASE/MLINJECTABLE / INJECTION2008-11-10301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A078511-002MIDAZOLAM HYDROCHLORIDEEQ 5MG BASE/MLINJECTABLE / INJECTION2008-11-10301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A078511-001MIDAZOLAM HYDROCHLORIDEEQ 1MG BASE/MLINJECTABLE / INJECTION2008-11-101e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A078511-002MIDAZOLAM HYDROCHLORIDEEQ 5MG BASE/MLINJECTABLE / INJECTION2008-11-101e350fbaab3a…
2024-05-31 18:47 UTC2024-05A078511-001MIDAZOLAM HYDROCHLORIDEEQ 1MG BASE/MLINJECTABLE / INJECTION2008-11-108072bd15b7f6…
2024-05-31 18:47 UTC2024-05A078511-002MIDAZOLAM HYDROCHLORIDEEQ 5MG BASE/MLINJECTABLE / INJECTION2008-11-108072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A078511-001MIDAZOLAM HYDROCHLORIDEEQ 1MG BASE/MLINJECTABLE / INJECTION2008-11-105c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A078511-002MIDAZOLAM HYDROCHLORIDEEQ 5MG BASE/MLINJECTABLE / INJECTION2008-11-105c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A078511-001MIDAZOLAM HYDROCHLORIDEEQ 1MG BASE/MLINJECTABLE / INJECTION2008-11-105d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A078511-002MIDAZOLAM HYDROCHLORIDEEQ 5MG BASE/MLINJECTABLE / INJECTION2008-11-105d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A078511-001MIDAZOLAM HYDROCHLORIDEEQ 1MG BASE/MLINJECTABLE / INJECTION2008-11-104b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A078511-002MIDAZOLAM HYDROCHLORIDEEQ 5MG BASE/MLINJECTABLE / INJECTION2008-11-104b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A078511-001MIDAZOLAM HYDROCHLORIDEEQ 1MG BASE/MLINJECTABLE / INJECTION2008-11-1074a2ff9319b5…
2019-12-13 00:20 UTC2019-12A078511-002MIDAZOLAM HYDROCHLORIDEEQ 5MG BASE/MLINJECTABLE / INJECTION2008-11-1074a2ff9319b5…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
MIDAZOLAM HYDROCHLORIDEACTIVE INGREDIENTW7TTW573JJMIDAZOLAM HYDROCHLORIDE INJECTION [WOCKHARDT USA LLC.]1
MIDAZOLAMACTIVE MOIETYR60L0SM5BCMIDAZOLAM HYDROCHLORIDE INJECTION [WOCKHARDT USA LLC.]1
HYDROCHLORIC ACIDINACTIVE INGREDIENTQTT17582CBMIDAZOLAM HYDROCHLORIDE INJECTION [WOCKHARDT USA LLC.]1
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8XMIDAZOLAM HYDROCHLORIDE INJECTION [WOCKHARDT USA LLC.]1
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32IMIDAZOLAM HYDROCHLORIDE INJECTION [WOCKHARDT USA LLC.]1